Roke Biotechnologies was founded in 2020 by Mike Lynch and co-founders Romel Menacho-Melgar, John Decker, Adim Moreb, and Jennifer Hennigan. The company is aimed at commercializing novel 2-stage protein expression and purification technologies enabling advances in processes for making proteins used in research as well as in the industrial and the pharmaceutical industries.
